EPF-001

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameEPF-001
Drug Alias NameRK-701EPF-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitors
TargetsHistone-lysine N-methyltransferase EHMT2
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTokyo University of Pharmacy and Life SciencesRiken
China Registration ClassN/A

Develop Information

Active CompaniesRikenEpiFrontier Therapeutics IncTokyo University of Pharmacy and Life Sciences
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A